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Edited by Judit Ova´diAbstract The skl gene from Streptococcus mitis SK137 en-
codes a peptidoglycan hydrolase (Skl) that has been puriﬁed
and biochemically characterized. Analysis of the degradation
products obtained by digestion of pneumococcal cell walls with
Skl revealed that this enzyme is an N-acetylmuramoyl-L-alanine
amidase (EC 3.5.1.28), showing optimum activity at 30 C and
at a pH of 6.5. Skl is a unique member of the choline-binding
family of proteins since it contains a cysteine, histidine-depen-
dent amidohydrolases/peptidases (CHAP) domain. The CHAP
domain of Skl showed homology to lysins of unknown especiﬁc-
ity from a variety of streptococcal prophages. Skl represents the
ﬁrst characterized member of a new subfamily of CHAP-con-
taining choline-binding proteins.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Choline-binding proteins (CBPs) bind to phosphorylcholine
(PC) residues present in the teichoic and lipoteichoic acids lo-
cated at the surface of several Gram-positive bacteria, mainly
Streptococcus pneumoniae and other streptococci of the mitis
group [1]. Binding of CBPs to PC residues is carried out by
a specialized protein domain named the choline-binding do-
main (CBD) that is constituted by a tandem of about 20 resi-
due repeats (choline-binding repeats). The three-dimensional
structure of the CBD from two pneumococcal and one
phage-coded CBPs has been recently determined [2–4]. Most
of our current knowledge on CBPs has been achieved by the
study of lytic enzymes (lysins) encoded by S. pneumoniae and
its phages [5–7]. Pneumococcal and phage lysins hydrolyze spe-
ciﬁc bonds in the peptidoglycan network: the N-acetylmura-
moyl-L-alanine amide bond between the glycan strand andAbbreviations: CBD, choline-binding domain; CBP, choline-binding
protein; CHAP, cysteine, histidine-dependent amidohydrolases/pepti-
dases; GSP, glutathionylspermidine; IPTG, isopropyl-b-D-thiogalacto-
pyranoside; ME, 2-mercaptoethanol; NAM-amidase, N-acetyl-
muramoyl-L-alanine amidase; PB, 20 mM sodium phosphate buﬀer;
PC, phosphorylcholine; U, unit of enzymatic activity
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doi:10.1016/j.febslet.2006.02.060the cross-linking peptide (N-acetylmuramoyl-L-alanine ami-
dase, NAM-amidases; EC 3.5.1.28), or the 1,4-b-linkage be-
tween N-acetylmuramic acid and N-acetyl-D-glucosamine
residues of the glycan chain (lysozymes; EC 3.2.1.17) [5,7]
(Fig. 1A). In addition to S. pneumoniae and its phages, CBPs
with lytic activity are encoded by four prophages from Strep-
tococcus mitis, namely, the NAM-amidases from EJ-1 (Ejl),
SM1 (gp56), and /B6 (LytAB6) and /HER (LytAHER) [7].
Gp56 is very similar (72% identical; 85% similar) to the Dp-1
NAM-amidase (Pal) whereas Ejl, LytAB6 and LytAHER are
more than 80% identical to the NAM-amidases LytA, Hbl,
Mml, and LytAVO1 encoded by S. pneumoniae and its temper-
ate phages HB-3, MM1, and VO1, respectively [7]. Although
many CBPs with lytic activity have been reported, it should
be underlined that only ﬁve diﬀerent molecular designs have
been reported so far (Fig. 1B).
We report here the puriﬁcation and characterization of a no-
vel CBP with NAM-amidase activity (Skl) that possesses an
enzymatic domain completely diﬀerent from those previously
characterized in this system. Skl represents the ﬁrst example
of an evolutionary link between other previously described
classes of enzymes.2. Materials and methods
2.1. Bacterial strains and plasmids
The S. mitis strain SK137 [8] was kindly provided by U.B.S. Søren-
sen from the University of Aarhus (Denmark). We also used the com-
mon pneumococcal R6 strain [9]. Escherichia coliDH10B [10] was used
as recipient of plasmid constructs. Plasmids pUC18 [10] and pIN-III
(lppp-5)-A3 [11] were employed for cloning and overexpression of the
S. mitis lysin gene, respectively.
2.2. Cloning, PCR ampliﬁcation, and nucleotide sequencing
Chromosomal DNA was prepared from cultures of S. mitis SK137
that had been treated with mitomycin C (75 ng/ml) for 1 h at 37 C
(see below). To clone the lysin gene, a genomic library was constructed
by ligating a DraI digestion of S. mitis SK137 DNA to SmaI-digested
pUC18, and the ligation mixture used to transform competent E. coli
DH10B cells. E. coli cells harboring recombinant plasmids were selected
among the ampicillin-resistant transformants that showed a white phe-
notype in the presence of isopropyl-b-D-thiogalactopyranoside (IPTG)
and 5-bromo-4-chloro-3-indolyl-b-D-galactoside. One of those plas-
mids (pFSK1) contained an insert of 3841 bp, and expressed a detect-
able lytic activity (see below). To overexpress the skl gene, skl was
PCR ampliﬁed with primers sk19 (5 0-gcTctagATGTCTAAAAAA-
CAGGAAATGATTC-3 0), and sk20 (5 0-gcAagcTTCTATTTCGTAG-
TAATCAAGCCTTCTG-3 0). Lowercase letters indicate nucleotides
introduced to construct appropriate restriction sites; these are shown
underlined. The ampliﬁed product was digested with XbaI andHindIII,
ligated to pIN-III (lppp-5)-A3 previously digested with the sameblished by Elsevier B.V. All rights reserved.
Fig. 1. Schematic representation of the S. pneumoniae cell wall and of the pneumococcal and phage cell wall hydrolases. (A) The structure of the
peptide network of the S. pneumoniae peptidoglycan is based on previous data [9]. The diﬀerent lytic enzymes are shown in brackets. Cpl-1 and Cpl-7
are muramidases (lysozymes; EC 3.2.1.17) from phages Cp-1 and Cp-7, respectively. The NAM-amidases Pal, Hbl, Ejl, Mml, and LytAVO1 are
encoded, respectively by phages Dp-1, HB-3, EJ-1, MM1, and VO1. Glucosaminidases, transglycosylases, endopeptidases and PC esterases encoded
by pneumococcal phages have not been described although S. pneumoniae synthesizes a glucosaminidase (LytB) and a PC esterase (Pce). Lytic
transglycosylases diﬀer from lysozymes by catalyzing an intramolecular transglycosylation of the glycosyl bond onto the C6 hydroxyl group of the
muramic acid residue, thus forming a 1,6-anhydromuramic acid derivative. Endopeptidases cleaving bonds diﬀerent to those shown in the ﬁgure are
also possible theoretically. TA, teichoic acid. Solid circles represent PC residues. (B) Six diﬀerent molecular architectures of the lytic enzymes of the
pneumococcal system. Sequence similarity among lysins is indicated by an equal shadowing. Each protein is identiﬁed by its name, number of amino
acid residues (aa), and Accession Number. Solid, gray, striped, and crosshatched bars represent, respectively, the lysozyme (Glyco_hydro_25 family;
PF01183), the amidase_2 (PF01510), the amidase_5 (PF05382), and the CHAP (PF05257) domains from the Pfam database. The substrate-binding
domains either a CBD (PF01473) (open boxes) or not (PF08230) (stippled boxes) are also shown. Cpl-7 is a choline-independent lysozyme [7].
1960 D. Llull et al. / FEBS Letters 580 (2006) 1959–1964enzymes, and used to transform E. coli DH10B. The suitable plasmid
(pFSK6) was selected among the ampicillin-resistant transformants
by checking the lytic activity of crude sonicated extracts on pneumococ-
cal cell walls. Primers Fag1 and Fag2 have been previously described
[11].
2.3. Overproduction and puriﬁcation of Skl
E. coli DH10B (pFSK6) cells were incubated in LB medium contain-
ing ampicillin (100 lg/ml) at 30 C with shaking until A600  0.6. Then,
IPTG (50 lM) was added and incubation continued overnight. The
culture was centrifuged (10000 · g, 5 min, 4 C) and the sedimented
bacteria were resuspended in 20 mM sodium phosphate buﬀer (PB)
(pH 6.9) and disrupted in a French Pressure Cell Press. The insoluble
fraction was separated by ultracentrifugation (100000 · g, 60 min,
4 C), and the supernatant was loaded onto a DEAE-cellulose columnto purify the lysin in a single step [12]. Unless otherwise stated, the en-
zyme was dialyzed against 20 mM PB (pH 6.5), and stored frozen at
20 C. Typically, up to 30 mg of puriﬁed Skl were obtained from
1 l of culture.
2.4. Preparation of radioactively labeled cell walls and analysis of the
degradation products
Pneumococcal and S. mitis cell walls were radioactively labeled
with [methyl-3H] choline or L-[4,5-3H] lysine as described [9]. Cell wall
lytic activity was determined using labeled cell walls as substrate [11].
One unit of enzymatic activity was deﬁned as the amount of enzyme
that catalyzed the hydrolysis (solubilization) of 1 lg of cell wall
material in 10 min. Under our experimental conditions, 1 lg of [3H ]
choline-labeled cell walls corresponds, approximately, to 700 net
cpm.
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scribed [13]. Brieﬂy, 200 ll of [3H ]choline- or [3H] lysine-labeled pneu-
mococcal cell walls (0.3 mg dry weight/ml; 7 · 105 cpm/ml) were
incubated for 18 h with 3000 U of the enzyme at 30 C in PB (pH
6.5) containing 10 mM 2-mercaptoethanol (ME), in a total volume
of 0.5 ml. The mixture was heated to 65 C for 15 min to inactivate
the enzyme, and centrifuged (12000 · g, 15 min) at room temperature.
For analytical purposes, a 100-ll sample of the supernatant that con-
tains the solubilized material was applied onto a Sephadex G-75 col-
umn (45 · 1.5 cm), eluted with 20 mM Tris–HCl buﬀer (pH 7.0)
containing 150 mM NaCl, and the radioactivity of the fractions
(1 ml) was determined. Muropeptides were puriﬁed by chromatogra-
phy of the supernatant obtained from Skl-digested, [3H] lysine-labeled
pneumococcal cell walls, in a Bio-Gel P4 (Bio-Rad) column
(90 · 2.5 cm). Peptide elution was performed with 0.1 M ammonium
acetate buﬀer (pH 7.0). The labeled peptides, were pooled, lyophilized,
and used for peptide sequencing (Edman degradation) [9].Fig. 2. Genetic organization around the skl gene coding for the lytic
enzyme and puriﬁcation of Skl. (A) Genes are represented as arrows
showing their length and the direction of transcription. An scheme of
the modular organization of the Skl protein is also shown. Open boxes
represent the CBD located C-terminally. (B) SDS–PAGE analysis of a
Skl lysin preparation puriﬁed by aﬃnity chromatography in DEAE
cellulose (lane 4). Crude, sonicated extracts obtained from E. coli
DH10B cells harboring the vector pIN-III (lppp-5)-A3 (lane 1), or the
recombinant plasmid pFSK6 either uninduced (lane 2) or induced
overnight with 50 lM IPTG (lane 3) are also shown. The molecular
mass of the standards (S), in kDa, is indicated at the left. (C)
Peptidoglycan hydrolase activity of Skl on pneumococcal and S. mitis
cell walls. The S. pneumoniae NAM-amidase LytA and the Cpl-1
lysozyme from phage Cp-1 are included as controls.3. Results
3.1. Sequencing of the skl lysin gene
During preliminary searches of temperate phages in S. mitis,
we noted that strain SK137 treated with mitomycin C lysed
after3 h of incubation, and that the corresponding cleared ly-
sates showed lytic activity when tested on radioactively labeled,
pneumococcal (or S. mitis) cell walls (not shown). Although
these ﬁndings suggested the presence of a prophage in SK137,
repeated attempts to purify complete virions failed. However,
as the possibility that the lytic activity was encoded by a defec-
tive prophage could not be ruled out, cloning of the skl gene
was performed by using DNA prepared from a mitomycin C-
induced culture of S. mitis SK137 (see above) and the insert
of plasmid pFSK1 was sequenced (AM040720). Four ORFs
were found (Fig. 2A) that showed a perfect synteny (holin-ly-
sin-integrase) with that expected for the virion DNA from a
temperate phage [14]. Although this possibility agreed with
the ﬁnding that the lytic activity in S. mitis SK137 arose only
after mitomycin C induction, further work is required to ascer-
tain whether skl belongs to an inducible, defective prophage.
The leftmost ORF (hol) encodes a putative phage holin (85
amino acid residues) sharing 93% identity with the holin
(Q708K1) of phage EJ-1 [7], whereas the rightmost ORF codes
for a protein of 382 amino acid residues (Int) that is 61% iden-
tical (78% similar) to the integrase of the Streptococcus pyoge-
nes phage 315.1 (NP_795373). Downstream of the int gene
there is another ORF (orf3) that showed 50% identity (61%
similarity) to ORF058 (YP_239820), an ORF of unknown
function located at an equivalent position in the Staphylococ-
cus aureus temperate siphovirus 2638A. The skl gene, located
between hol and orf3, encodes a 288 amino acid protein (pre-
dicted Mr 33527) containing a CBD located at its C-terminal
moiety (Fig. 2A) that is 69% identical (79% similar) to that
of LytAB6 (Q706F5). Quite surprisingly, the N-terminal do-
main of Skl showed no similarities with any of the CBPs cur-
rently known but it was 61% identical (74% similar) (over 144
amino acid residues) to part of the putative cell wall hydrolase
(Ph2) encoded by a Streptococcus equi prophage (Q8GMW0).
A search of the InterProKB database showed that the N-termi-
nal moiety of Skl corresponds to a cysteine, histidine-depen-
dent amidohydrolases/peptidases (CHAP) domain (PF05257)
[15,16]. Sequence alignments of Skl with other proteins con-
taining a CHAP domain predicted Cys-31 and His-92 as the
residues of the CHAP domain putatively involved in enzymatic
activity (not shown).3.2. Biochemical properties of the Skl lysin
The skl gene, putatively encoding a lysin, was PCR ampliﬁed,
cloned and expressed in E. coli. The overexpressed 35-kDa
protein was puriﬁed to homogeneity by aﬃnity chromatogra-
phy in DEAE-cellulose (Fig. 2B), and its N-terminal amino
acid sequence determined (MSKKQE), conﬁrming the deduced
amino acid sequence predicted from the nucleotide sequence.
As a Cys residue might be involved in activity, enzymatic assays
were performed using either dithiothreitol or ME. A twofold
increase in the cell wall degrading activity of Skl was found
when either of those chemicals was used at 10 mM (not shown).
Moreover, puriﬁed Skl degraded with equivalent eﬃciency [3H]
choline-labeled cell walls either from pneumococcus or S. mitis
(Fig. 2C).
It has been observed that most CBPs displayed full enzy-
matic activity after elution from the DEAE-cellulose column
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Skl although its enzymatic activity was drastically reduced
after the dialysis step (Table 1) in remarkable contrast with
that reported for the pneumococcal LytA NAM-amidase or
the Cpl-1 lysozyme [5,7]. To reach full enzymatic activity,
Skl must be preincubated (5 min) with choline-containing cell
walls at 0 C (Table 1). In agreement with the choline-binding
nature of Skl, the addition of 2% choline chloride drastically
inhibited the enzyme. Other features of the Skl enzyme were
that optimal activity was reached when assayed at 30 C rather
than at 37 C and at pH of about 6.5 (Fig. 3). Highly puriﬁed
preparations of Skl did not require the addition of any divalent
cation for optimal activity (not shown), although the inhibi-
tory eﬀect of EDTA or EGTA (Table 1) suggested that diva-
lent cations may be associated with the pure enzyme and be
required for activity and/or structural stability, as alreadyTable 1
Biochemical properties of the Skl lysin
Additionsa Enzyme activity (%)b
None 100
No conversionc 15 ± 0.8
EDTA (1 mM)d 4 ± 0.1
EDTA (1 mM) + MgCl2 (2 mM) 20 ± 0.3
EDTA (1 mM) + CaCl2 (2 mM) 100 ± 3
EDTA (1 mM) + MnCl2 (2 mM) 67 ± 0.3
EDTA (1 mM) + ZnCl2 (2 mM) 4 ± 0.1
EGTA (1 mM)d 3 ± 0.1
EGTA (1 mM) + CaCl2 (2 mM) 100 ± 2
aThe standard reaction mixture contains [3H] choline-labeled pneu-
mococcal cell walls (10 ll; 7.5 · 105 cpm/ml), puriﬁed and dialyzed Skl
(5 U), 10 mM ME, and 20 mM sodium phosphate buﬀer (pH 6.5) in a
ﬁnal volume of 250 ll. Unless stated otherwise, the mixture, with or
without additions, was preincubated for 5 min at 0 C, and then for
10 min at 30 C.
bValues are the average of four independent determinations ± standard
error.
cThe preincubation step at 0 C was omitted.
dEDTA (or EGTA) was added 5 min before the divalent cation.
Fig. 3. Dependence of activity of the Skl amidase on pH of the
incubation buﬀer (left) and temperature reaction (right). Skl activity
was tested at various pH values in 20 mM sodium phosphate (d) and
in 20 mM sodium acetate (s) buﬀer under standard assay conditions
with an enzyme concentration of 20 U/ml. Values are the mean of three
independent experiments. Error bars are also shown.shown for other enzymes, e.g., a-amylases (see [17] and refer-
ences therein). Moreover, removal of divalent cations from
Skl appears to be reversible, and Ca2+ (at 1 mM) appears to
be preferred over Mn2+, whereas addition of Mg2+ to an
EDTA-inhibited reaction mixture lacked any clear eﬀect (Ta-
ble 1). Nevertheless, to ascertain whether Skl is a Ca2+-con-
taining metalloenzyme, will require additional work.
3.3. Biochemical characterization of Skl
Pneumococcal cell walls labeled either with [3H] choline or
[3H] lysine were digested with puriﬁed Skl, and the solubilizedFig. 4. Gel ﬁltration of hydrolytic products released from pneumo-
coccal cell walls treated with Skl. [3H] choline- (d) or [3H] lysine-
labeled (s) pneumococcal cell walls were treated with Skl and the
solubilized products were analyzed by gel ﬁltration on a Sephadex G-
75, or Bio-Gel P4 column, as detailed in Section 2. V0 and Vt indicate
the void volume and the bed volume of the columns, respectively. In
the case of the Bio-Gel P4 column, 0.5 ml of each fraction (5 ml) were
counted. Black bars represent fractions that were pooled and analyzed
separately. Incompletely degraded cell wall products are excluded from
the column and eluted at V0.
Table 2
Proteins of the CHAP family that have been characterized biochemically
Entry name (Accession No.)a Enzymatic activityb Reference
DPP6_BACSH (P39043)c c-D-Glutamyl-meso-diaminopimelate endopeptidase [22]
GSP_ECOLI (P0AES0) GSP synthethase/amidase [23]
LYTF_BACSU (O07532)c c-D-Glutamyl-meso-diaminopimelate endopeptidase [24]
Q8SDS7_BPPHA (Q8SDS7) D-Alanyl-glycyl endopeptidase and NAM-amidase [25]
GSP_CRIFA (P90518) GSP synthethase/amidase [26]
Q95WL5_TRYCR (Q95WL5) Trypanothione synthetase/amidase [27]
PGDS_BACSU (P96740)c c-DL-Glutamyl hydrolase [28]
Q8HA43_9CAUD (Q8HA43) D-Alanyl-L-alanyl endopeptidase and lysozyme [29]
Q5DM89_CRIFA (Q5DM89) Trypanothione synthetase/amidase [30]
aData corresponding to the UniProt Knowledgebase (UniProtKB).
bFor bifunctional proteins, the activity of the CHAP domain is italicized.
cProtein containing NlpC/P60, a CHAP-related domain [31].
D. Llull et al. / FEBS Letters 580 (2006) 1959–1964 1963products were analyzed by gel ﬁltration as described in Section
2. [3H] choline-labeled cell wall products were excluded from
the Sephadex G-75 column whereas [3H] lysine-labeled prod-
ucts eluted at or near Vt (Fig. 4). These elution patterns
showed that Skl promoted the separation of the glycan chains
associated with the choline-containing teichoic acids from the
lysine-containing muropeptides and indicated that Skl is either
an NAM-amidase or an endopeptidase (Fig. 1A). A prepara-
tion of muropeptides was obtained by gel ﬁltration in a Bio-
Gel P4 column (Fig. 4), and the N-terminal amino acid deter-
mined in the three pooled fractions, yielding Ala in all cases
(not shown). These results taken together demonstrated that
Skl is an NAM-amidase.4. Discussion
The S. mitis strain SK137 encodes a modular lytic enzyme
(Skl) that belongs to the CBP family. Nevertheless, in sharp
contrast with other previously characterized CBP lysins, Skl
contains a CHAP domain. More than 360 proteins containing
a CHAP domain are included in the Pfam database (last date
accessed, 16 January 2006). Although it has been proposed that
proteins containing a CHAP domain may function mainly in
peptidoglycan hydrolysis [15,16], it should be emphasized that,
compelling biochemical evidence on the precise bond(s) hydro-
lyzed has been reported only in few cases (Table 2). Usually,
proteins having a CHAP domain are merely annotated in the
databases as ‘‘peptidoglycan hydrolase’’, ‘‘lytic enzyme’’, or
similar generic designations. Besides, Rigden and coworkers
[15] recently pointed out that only 11 members of the CHAP
family (including members of the NlpC/P60 family) are bio-
chemically characterized (as ‘‘amidases’’). However, GSP_E-
COLI, GSP_CRIFA, Q95WL5_TRYCR, Q5DM89_CRIFA,
and PGDS_BACSU were completely unrelated to cell wall deg-
radation functions (Table 2). Furthermore, only two of the
other seven proteins that, presumably, degrade cell walls have
been precisely characterized, i.e., the bifunctional lysins en-
coded by the staphylococcal phage /11 and the Streptococcus
agalactiae phage B30. Most probably, the lysins of the /11-
related staphylococcal phages 187 (O56785), Twort (O56788),
/PVL (O80064), and WMY (Q5NTY4) also have endopepti-
dase/NAM-amidase activities.
In this work we have shown that Skl is a NAM-amidase and,
on the basis of the data mentioned above, it constitutes the ﬁrst
enzyme of this type containing a CHAP domain. It is impor-tant to highlight that sequence comparisons revealed that the
CHAP domain of Skl is closely related (E values ranging from
1041 to 1015) to that of 20 diﬀerent cell wall hydrolases en-
coded by S. pyogenes prophages. Lower (but signiﬁcant) se-
quence similarities were found with the lysins of phages
Twort (E = 106) and /PVL (E = 104) whereas meaningless
similarity (EP 0.16) was found with the CHAP domain of
the S. aureus phage /11 or the S. agalactiae phage B30 lysins.
These results taken together strongly suggested that Skl is the
ﬁrst member of a subfamily of NAM-amidases containing a
CHAP domain. This subfamily embraces, mainly, lytic en-
zymes encoded by Streptococcus prophages that are being de-
scribed mainly by genomic sequencing. Recently, CbpD
(Q8DMZ4), a CBP encoded by S. pneumoniae that also con-
tains a CHAP domain, has been proposed as a murein hydro-
lase that functions as a competence-speciﬁc lysin [18,19].
Unfortunately, the enzymatic speciﬁcity of CbpD is still un-
known and no signiﬁcant sequence similarity between the
CHAP domain of CbpD and Skl was found. The CHAP do-
main of PcsB (Q8DMY4), which is not a CBP, appears to be
involved in cell wall synthesis and/or degradation in the pneu-
mococcus [20] but it has no sequence similarity with Skl. Con-
sequently, Skl is the ﬁrst example of a new type of CBP having
NAM-amidase activity and possessing a CHAP domain, and
represents a novel, distinctive example of the modular evolu-
tion of lytic enzymes [21].
Acknowledgments: We thank P. Garcı´a and M. Moscoso for critically
reading the manuscript. This work was supported by grants from the
Direccio´n General de Investigacio´n Cientı´ﬁca y Te´cnica (BMC2003-
00074) and from Redes Tema´ticas de Investigacio´n Cooperativa
(G03/103 and C03/14).References
[1] Garcı´a, J.L., Sa´nchez-Beato, A.R., Medrano, F.J. and
Lo´pez, R. (2000) Versatility of choline-binding domain in:
Streptococcus pneumoniae – Molecular Biology & Mechanisms of
Disease (Tomasz, A., Ed.), pp. 231–244, Mary Ann Liebert,
Larchmont, NY.
[2] Ferna´ndez-Tornero, C., Lo´pez, R., Garcı´a, E., Gime´nez-Gallego,
G. and Romero, A. (2001) A novel solenoid fold in the cell wall
anchoring domain of the pneumococcal virulence factor LytA.
Nat. Struct. Biol. 8, 1020–1024.
[3] Hermoso, J.A. et al. (2003) Structural basis for selective recog-
nition of pneumococcal cell wall by modular endolysin from
phage Cp-1. Structure 11, 1239–1249.
[4] Hermoso, J.A., Lagartera, L., Gonza´lez, A., Stelter, M., Garcı´a,
P., Martı´nez-Ripoll, M., Garcı´a, J.L. and Mene´ndez, M. (2005)
1964 D. Llull et al. / FEBS Letters 580 (2006) 1959–1964Insights into pneumococcal pathogenesis from crystal structure of
the modular teichoic acid phosphorylcholine esterase Pce. Nat.
Struct. Mol. Biol. 12, 533–538.
[5] Lo´pez, R., Garcı´a, E., Garcı´a, P. and Garcı´a, J.L. (2004) Cell wall
hydrolases in: The Pneumococcus (Tuomanen, E.I., Mitchell,
D.A., Morrison, D.A. and Spratt, B.G., Eds.), pp. 75–88, ASM
Press, Washington, DC.
[6] Lo´pez, R. and Garcı´a, E. (2004) Recent trends on the molecular
biology of pneumococcal capsules, lytic enzymes, and bacterio-
phage. FEMS Microbiol. Rev. 28, 553–580.
[7] Garcı´a, P., Garcı´a, J.L., Lo´pez, R. and Garcı´a, E. (2005)
Pneumococcal phages in: Phages: Their Role in Bacterial Path-
ogenesis and Biotechnology (Waldor, M.K., Friedman, D.L.I.
and Adhya, S., Eds.), pp. 335–361, ASM Press, Washington, DC.
[8] Bergstro¨m, N., Jansson, P.E., Kilian, M. and Sørensen, U.B.S.
(2000) Structures of two cell wall-associated polysaccharides of a
Streptococcus mitis biovar 1 strain. A unique teichoic acid-like
polysaccharide and the group O antigen which is a C-polysac-
charide in common with pneumococci. Eur. J. Biochem. 267,
7147–7157.
[9] Garcia-Bustos, J.F. and Tomasz, A. (1990) A biological price of
antibiotic resistance: major changes in the peptidoglycan structure
of penicillin-resistant pneumococci. Proc. Natl. Acad. Sci. USA
87, 5415–5419.
[10] Sambrook, J. and Russell, D.W. (2001) Cold Spring Harbor, Cold
Spring Harbor Laboratory Press, New York.
[11] Romero, P., Lo´pez, R. and Garcı´a, E. (2004) Characterization of
LytA-like N-acetylmuramoyl-L-alanine amidases from two new
Streptococcus mitis bacteriophages provides insights into the
properties of the major pneumococcal autolysin. J. Bacteriol. 186,
8229–8239.
[12] Sa´nchez-Puelles, J.M., Sanz, J.M., Garcı´a, J.L. and Garcı´a, E.
(1992) Immobilization and single-step puriﬁcation of fusion
proteins using DEAE-cellulose. Eur. J. Biochem. 203, 153–
159.
[13] Garcı´a, P., Me´ndez, E., Garcı´a, E., Ronda, C. and Lo´pez, R.
(1984) Biochemical characterization of a murein hydrolase
induced by bacteriophage Dp-1 in Streptococcus pneumoniae:
comparative study between bacteriophage-associated lysin and
host amidase. J. Bacteriol. 159, 793–796.
[14] Canchaya, C., Proux, C., Fournous, G., Bruttin, A. and Bru¨ssow,
H. (2003) Prophage genomics. Microbiol. Mol. Biol. Rev. 67,
238–276.
[15] Rigden, D.J., Jedrzejas, M.J. and Galperin, M.Y. (2003) Amidase
domains from bacterial and phage autolysins deﬁne a family of c-
D,L-glutamate-speciﬁc amidohydrolases. Trends Biochem. Sci. 28,
230–234.
[16] Bateman, A. and Rawlings, N.D. (2003) The CHAP domain: a
large family of amidases including GSP amidase and peptidogly-
can hydrolases. Trends Biochem. Sci. 28, 234–237.
[17] Nielsen, A.D., Fuglsang, C.C. and Westh, P. (2003) Eﬀect of
calcium ions on the irreversible denaturation of a recombinant
Bacillus halmapalus a-amylase: a calorimetric investigation. Bio-
chem. J. 373, 337–343.[18] Guiral, S., Mitchell, T.J., Martin, B. and Claverys, J.-P. (2005)
Competence-programmed predation of noncompetent cells in the
human pathogen Streptococcus pneumoniae: genetic requirements.
Proc. Natl. Acad. Sci. USA 102, 8710–8715.
[19] Kausmally, L., Johnsborg, O., Lunde, M., Knutsen, E. and
Ha˚varstein, L.S. (2005) Choline-binding protein D (CbpD) in
Streptococcus pneumoniae is essential for competence-induced cell
lysis. J. Bacteriol. 187, 4338–4345.
[20] Ng, W.-L., Kazmierczak, K.M. and Winkler, M.E. (2004)
Defective cell wall synthesis in Streptococcus pneumoniae R6
depleted for the essential PcsB putative murein hydrolase or the
VicR (YycF) response regulator. Mol. Microbiol. 53, 1161–1175.
[21] Lo´pez, R., Garcı´a, E., Garcı´a, P. and Garcı´a, J.L. (2000) The
pneumococcal cell wall degrading enzymes: a modular design to
create new lysins? in: Streptococcus pneumoniae – Molecular
Biology & Mechanisms of Disease (Tomasz, A., Ed.), pp. 197–
209, Mary Ann Liebert, Inc, Larchmont, NY.
[22] Hourdou, M.-L., Duez, C., Joris, B., Vacheron, M.-J., Guinand,
M., Michel, G. and Ghuysen, J.-M. (1992) Cloning and nucleotide
sequence of the gene encoding the c-D-glutamyl-L-diamino acid
endopeptidase II of Bacillus sphaericus. FEMS Microbiol. Lett.
91, 165–170.
[23] Bollinger, J.M.J., Kwon, D.S., Huisman, G.W., Kolter, R. and
Walsh, C.T. (1995) Glutathionylspermidine metabolism in Esch-
erichia coli. Puriﬁcation, cloning, overproduction, and character-
ization of a bifunctional glutathionylspermidine sythetase/
amidase. J. Biol. Chem. 270, 14031–14041.
[24] Margot, P., Pagni, M. and Karamata, D. (1999) Bacillus subtilis
168 gene lytF encodes a c-D-glutamate-meso-diaminopimelate
muropeptidase expressed by the alternative vegetative sigma
factor, rD. Microbiology 145, 57–65.
[25] Navarre, W.W., Ton-That, H., Faull, K.F. and Schneewind, O.
(1999) Multiple enzymatic activities of the murein hydrolase from
staphylococcal phage /11. Identiﬁcation of a D-alanyl-glycine
endopeptidase activity. J. Biol. Chem. 274, 15847–15856.
[26] Oza, S.L., Ariyanayagam, M.R. and Fairlamb, A.H. (2002)
Characterization of recombinant glutathionylspermidine synthe-
tase/amidase from Crithidia fasciculata. Biochem. J. 364, 679–686.
[27] Oza, S.L., Tetaud, E., Ariyanayagam, M.R., Warnon, S.S. and
Fairlamb, A.H. (2002) A single enzyme catalyses formation of
trypanothione from glutathione and spermidine in Trypanosoma
cruzi. J. Biol. Chem. 277, 35853–35861.
[28] Suzuki, T. and Tahara, Y. (2003) Characterization of the Bacillus
subtilis ywtD gene, whose product is involved in c-polyglutamic
acid degradation. J. Bacteriol. 185, 2379–2382.
[29] Pritchard, D.G., Dong, S., Baker, J.R. and Engler, J.A. (2004)
The bifunctional peptidoglycan lysin of Streptococcus agalactiae
bacteriophage B30. Microbiology 150, 2079–2087.
[30] Comini, M., Menge, U., Wissing, J. and Flohe, L. (2005)
Trypanothione synthesis in Crithidia revisited. J. Biol. Chem.
280, 6850–6860.
[31] Anantharaman, V. and Aravind, L. (2003) Evolutionary history,
structural features and biochemical diversity of the NlpC/P60
superfamily of enzymes. Genome Biol. 4, R11.1–R11.12.
